Overexpression of ARRB2 induced expression of ENT1, which promotes influx of Gemcitabine into cancer cells, and was also shown to inhibit conversion of gemcitabine into inactive metabolites by inhibiting the enzyme Cytidine Deaminase (CDA). This evidence concerns the gene CDA and cancer.